These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 36109762)

  • 61. "Guide" of muscone modification enhanced brain-targeting efficacy and anti-glioma effect of lactoferrin modified DTX liposomes.
    Qi N; Duan W; Gao D; Ma N; Zhang J; Feng J; Li A
    Bioeng Transl Med; 2023 Mar; 8(2):e10393. PubMed ID: 36925685
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Tumor microenvironment-activated cancer cell membrane-liposome hybrid nanoparticle-mediated synergistic metabolic therapy and chemotherapy for non-small cell lung cancer.
    Zhang W; Gong C; Chen Z; Li M; Li Y; Gao J
    J Nanobiotechnology; 2021 Oct; 19(1):339. PubMed ID: 34689761
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
    Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H
    Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912
    [TBL] [Abstract][Full Text] [Related]  

  • 64. RGD(Arg-Gly-Asp) internalized docetaxel-loaded pH sensitive liposomes: Preparation, characterization and antitumor efficacy in vivo and in vitro.
    Zuo T; Guan Y; Chang M; Zhang F; Lu S; Wei T; Shao W; Lin G
    Colloids Surf B Biointerfaces; 2016 Nov; 147():90-99. PubMed ID: 27497073
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Development of liposomal Ginsenoside Rg3: formulation optimization and evaluation of its anticancer effects.
    Yu H; Teng L; Meng Q; Li Y; Sun X; Lu J; J Lee R; Teng L
    Int J Pharm; 2013 Jun; 450(1-2):250-8. PubMed ID: 23628402
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Stereoselective Anti-Cancer Activities of Ginsenoside Rg3 on Triple Negative Breast Cancer Cell Models.
    Nakhjavani M; Palethorpe HM; Tomita Y; Smith E; Price TJ; Yool AJ; Pei JV; Townsend AR; Hardingham JE
    Pharmaceuticals (Basel); 2019 Aug; 12(3):. PubMed ID: 31374984
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Ginsenoside Rg3 Alleviates Aluminum Chloride-Induced Bone Impairment in Rats by Activating the TGF-β1/Smad Signaling Pathway.
    Song M; Cui Y; Wang Q; Zhang X; Zhang J; Liu M; Li Y
    J Agric Food Chem; 2021 Nov; 69(43):12634-12644. PubMed ID: 34694773
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Novel pegylated liposomal formulation of docetaxel with 3-n-pentadecylphenol derivative for cancer therapy.
    Zawilska P; Machowska M; Wisniewski K; Grynkiewicz G; Hrynyk R; Rzepecki R; Gubernator J
    Eur J Pharm Sci; 2021 Aug; 163():105838. PubMed ID: 33845119
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Ccl3 enhances docetaxel chemosensitivity in breast cancer by triggering proinflammatory macrophage polarization.
    Sheng D; Ma W; Zhang R; Zhou L; Deng Q; Tu J; Chen W; Zhang F; Gao N; Dong M; Wang D; Li F; Liu Y; He X; Duan S; Zhang L; Liu T; Liu S
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35613826
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tumor microenvironment pH-responsive pentagonal gold prism-based nanoplatform for multimodal imaging and combined therapy of castration-resistant prostate cancer.
    Tan H; Liu Y; Hou N; Cui S; Liu B; Fan S; Yu G; Han C; Zheng D; Li W; Liu Y; Xu B; Wang Z; Cui D
    Acta Biomater; 2022 Mar; 141():408-417. PubMed ID: 35032718
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A stabilized retro-inverso peptide ligand of transferrin receptor for enhanced liposome-based hepatocellular carcinoma-targeted drug delivery.
    Tang J; Wang Q; Yu Q; Qiu Y; Mei L; Wan D; Wang X; Li M; He Q
    Acta Biomater; 2019 Jan; 83():379-389. PubMed ID: 30395963
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Ginsenoside Rg3 induces DNA damage in human osteosarcoma cells and reduces MNNG-induced DNA damage and apoptosis in normal human cells.
    Zhang YH; Li HD; Li B; Jiang SD; Jiang LS
    Oncol Rep; 2014 Feb; 31(2):919-25. PubMed ID: 24337872
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Docetaxel encapsulation in nanoscale assembly micelles of folate-PEG-docetaxel conjugates for targeted fighting against metastatic breast cancer in vitro and in vivo.
    Andisheh F; Oroojalian F; Shakour N; Ramezani M; Shamsara J; Khodaverdi E; Nassirli H; Hadizadeh F; Alibolandi M
    Int J Pharm; 2021 Aug; 605():120822. PubMed ID: 34182039
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ginsenoside Rg3 regulates DNA damage in non-small cell lung cancer cells by activating VRK1/P53BP1 pathway.
    Liu T; Zuo L; Guo D; Chai X; Xu J; Cui Z; Wang Z; Hou C
    Biomed Pharmacother; 2019 Dec; 120():109483. PubMed ID: 31629252
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Enhancing solid tumor therapy with sequential delivery of dexamethasone and docetaxel engineered in a single carrier to overcome stromal resistance to drug delivery.
    Zhang L; Su H; Liu Y; Pang N; Li J; Qi XR
    J Control Release; 2019 Jan; 294():1-16. PubMed ID: 30527754
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nano-delivery of salvianolic acid B induces the quiescence of tumor-associated fibroblasts via interfering with TGF-β1/Smad signaling to facilitate chemo- and immunotherapy in desmoplastic tumor.
    Chen Y; Hu M; Wang S; Wang Q; Lu H; Wang F; Wang L; Peng D; Chen W
    Int J Pharm; 2022 Jul; 623():121953. PubMed ID: 35753535
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Docetaxel/2-Hydroxypropyl β -Cyclodextrin Inclusion Complex Increases Docetaxel Solubility and Release from a Nanochannel Drug Delivery System.
    Ferrati S; Nicolov E; Bansal S; Hosali S; Landis M; Grattoni A
    Curr Drug Targets; 2015; 16(14):1645-9. PubMed ID: 25706254
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Metabolic profile of lung-targeted docetaxel liposomes in rabbits, rats and mice.
    Li M; Wang L; Li R; Zhang L; Wang J; Yu Y
    Xenobiotica; 2020 Feb; 50(2):125-134. PubMed ID: 30865477
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Multistage pH-responsive codelivery liposomal platform for synergistic cancer therapy.
    Zhao T; Liang C; Zhao Y; Xue X; Ma Z; Qi J; Shen H; Yang S; Zhang J; Jia Q; Du Q; Cao D; Xiang B; Zhang H; Qi X
    J Nanobiotechnology; 2022 Apr; 20(1):177. PubMed ID: 35366888
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pegylated liposomal encapsulation improves the antitumor efficacy of combretastatin A4 in murine 4T1 triple-negative breast cancer model.
    Mirzavi F; Barati M; Vakili-Ghartavol R; Roshan MK; Mashreghi M; Soukhtanloo M; Jaafari MR
    Int J Pharm; 2022 Feb; 613():121396. PubMed ID: 34942328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.